Breast and Ovarian Cancer Risk and Prevention
Research Studies
IRIS: Impact of Risk Inheritance Study
Why is this study being done?
Project IRIS was created to explore issues involving genetic testing and how it affects the way in which individuals and their families use genetic information in their lives. The study focuses on:
- Understanding of cancer risk, and
- Cancer screening and prevention practices.
Who is eligible?
All individuals who are planning to undergo genetic testing for inherited risk of breast, ovarian, colon or other gastrointestinal (digestive system) cancers are eligible to participate in IRIS.
What is involved?
IRIS is questionnaire study. We ask participants to complete a questionnaire:
- When they have decided to have genetic testing, or at the visit when blood is drawn for the genetic test;
- Two weeks after receiving their genetic test results;
- Three months after receiving their genetic test results; and
- Once a year for five years.
How do I get more information about the IRIS study?
Margery Rosenblatt
margery_rosenblatt@dfci.harvard.edu
(617) 632-3354
